Will the Biden administration’s short-term plan rule increase the uninsured rate?
Free-market advocates argue proposed restrictions on short-term plans will leave consumers without coverage. Health policy researchers aren’t so sure.
Free-market advocates argue proposed restrictions on short-term plans will leave consumers without coverage. Health policy researchers aren’t so sure.
The amount of private equity deals decreased 23.7% compared to the first quarter this year. However, Q2 deal volume was still 12.3% higher than the average quarterly deal count pre-pandemic, according to a report from PitchBook.
See how the latest in AI can move the conversation back to the forefront with clinical documentation that writes itself—all within the EHR—so clinicians can focus on their patients.
The value-based primary care chain posted a net loss of $270.7 million in the second quarter, nearly 19 times larger than its $14.6 million loss in the prior-year period.
The request for more information pushes back the timeline of the merger as regulators take a more active stance in healthcare M&A oversight.
Grant Thornton principal Lisa Walkush explains why healthcare remains one of the most attractive options for private equity firms.
The investment aims to reduce “bottlenecks in nurse training” that stakeholders say hamper recruitment efforts.
CEO Jeff Tangney attributed the company’s slowdown to “post-COVID upsell weakness,” while also reducing Doximity’s revenue guidance for fiscal year 2024.
Continuing financial pressures could keep deal-making low in the second half of the year, but M&A could heat up in early 2024, a new KPMG report finds.
Star ratings bonuses jumped 30% from 2022 to 2023 to reach $12.8 billion, according to the KFF, as the Medicare program faces a growing spending crisis.